- Home
- KRYS vs AXS Comparison
KRYS vs AXS Comparison
Compare KRYS & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRYS | AXS |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | Bermuda |
| Employees | N/A | 1876 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRYS | AXS |
|---|---|---|
| Price | $249.97 | $100.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $297.60 | $121.86 |
| AVG Volume (30 Days) | 260.2K | ★ 548.7K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 6.84 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $40.88 | $4.36 |
| Revenue Next Year | $35.16 | $6.20 |
| P/E Ratio | $36.15 | ★ $8.43 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $84.81 |
| 52 Week High | $298.30 | $110.34 |
Technical Indicators
Market Signals| Indicator | KRYS | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.69 | 43.08 |
| Support Level | $233.64 | $99.15 |
| Resistance Level | $293.60 | $103.58 |
| Average True Range (ATR) | 9.00 | 2.07 |
| MACD | -2.10 | -0.39 |
| Stochastic Oscillator | 14.28 | 26.97 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.